Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with active rheumatoid arthritis based on recognised international classification guidelines from 2010.
- People whose disease activity score across 28 joints (a standard measurement of rheumatoid arthritis severity) is above 2.6, indicating active disease.
- People between 18 and 60 years of age.
- Both men and women are eligible.
- People who are currently taking methotrexate alongside other standard arthritis treatments.
- People who are able to read and sign a written consent form agreeing to take part in the trial.
Who may not be able to join:
- People who have kidney or liver disease.
- People who have a known allergy or sensitivity to the medications being studied.
- People who are currently taking antioxidant supplements.
- People who have a history of psychiatric (mental health) disorders.
- People who are taking the steroid medication prednisolone at a dose higher than 15 mg per day.
- People who are currently being treated with a type of advanced arthritis medication known as biological disease-modifying drugs.
- People who are pregnant or breastfeeding.
- People who have a history of irregular heartbeat or a heart condition known as prolonged QT interval (a specific abnormality seen on a heart tracing).
- People who are taking any medications known to affect heart rhythm in a way associated with prolonged QT interval (confirm with trial site for a list of specific medications).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01028275001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Disease Activity Score (DAS28)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.